Cubosome dispersions as delivery systems for percutaneous administration of indomethacin.
about
Dynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunizationSelf-assembly in monoelaidin aqueous dispersions: direct vesicles to cubosomes transition.Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin.Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticlesCubic and hexagonal liquid crystals as drug delivery systems.Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.Preparation, characterisation and evaluation of curcumin with piperine-loaded cubosome nanoparticles.Superiority of liquid crystalline cubic nanocarriers as hormonal transdermal vehicle: comparative human skin permeation-supported evidence.Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery.Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation.Engineering nanomedicines for improved melanoma therapy: progress and promises.Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation.Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.Why Do Membranes of Some Unhealthy Cells Adopt a Cubic Architecture?Ocular drug delivery - a look towards nanobioadhesives.Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery.Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies.Effect of new curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses.Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol.Ethosomes and organogels for cutaneous administration of crocin.Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns.Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: characterization and in vitro and in vivo evaluation.Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.Gold Nanoparticles as a Direct and Rapid Sensor for Sensitive Analytical Detection of Biogenic Amines.In vitro skin permeation and anti-atopic efficacy of lipid nanocarriers containing water soluble extracts of Houttuynia cordata.Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation.In vitro and in vivo evaluation of indomethacin nanoemulsion as a transdermal delivery system.Development and evaluation of exemestane-loaded lyotropic liquid crystalline gel formulations.Rheological and textural properties of microemulsion-based polymer gels with indomethacin.Duodenum-triggered delivery of pravastatin sodium: II. Design, appraisal and pharmacokinetic assessments of enteric surface-decorated nanocubosomal dispersions.Optimization of the Preparation Process for an Oral Phytantriol-Based Amphotericin B Cubosomes
P2860
Q27320722-1E3B67B4-8163-4D1E-8302-223A4A1ADA14Q33385136-4B28A46D-AA5B-4E95-B051-FACC51E1EB3BQ33557899-C30654D4-F11E-4E0E-AD7B-6CE975A75DEAQ33573423-F219DBA6-226F-45EF-AE01-CA9EBD22C134Q33573467-05CE4E09-2862-4699-B67F-C0EB8EB51597Q33644850-00DE04CC-9ED8-4B97-9475-4AEA8708FA9CQ33796598-E40D8B40-4264-4FB2-94BB-43501798C3A3Q34280372-BF442E49-1D7F-4C44-A4FF-CEC42BCDC4F6Q35123608-000CDF7E-1D58-4A1B-8A51-F6F17373FD13Q36014479-2CBD1B83-B583-4750-80F0-1DCD7B67A71CQ36442187-3C8E84D5-CA66-44BA-9AF0-722DC48C0F4FQ36636516-A8B9A5D0-BDD3-4ABC-ABA6-EEB4F5CCBAA3Q36910413-5C8AC578-7E45-42AC-9F31-EF3B174E37F8Q36936646-004B7C20-0C46-48D7-B8A0-3A959F956EC8Q37126415-39F42E5B-B246-4805-A05D-E9E33EA49F42Q37283473-A2391C65-B7A8-4993-BE32-0FBC01063823Q37545528-955B2D04-BBB2-4F64-AA8C-19D3100A6694Q37822756-EBD51CAD-EE97-43DF-93E2-445EF52EB7F8Q38100238-C0DDB99F-C047-4DB7-8FBF-CBA4F230EF16Q38680101-2A5DAEFB-60E3-4C1B-8169-9313A4D77C4DQ38895315-B194111A-8B9C-4979-ADCB-5B8624FAF535Q38938549-9512B6AF-442B-4EA2-8EB2-F1DF30F5F5CDQ38948211-77D04C0D-D033-4312-8F99-407E2274DA59Q39199894-037EE6F1-52F9-499B-8178-C99498881BCEQ40547678-19303981-40E9-4DDC-B5D9-A0A7CB65F2E7Q41612480-7A32A0D5-666A-46C7-9C6B-C7DD87AA9561Q41619435-DF2E913F-97D1-403C-A135-607B2DBC3F78Q41864793-940E3D46-6828-46EF-9A02-D87B0749C0A0Q42293435-5CD85ED1-76F3-4C72-95C8-6A06EC96B453Q44990712-D9474BF1-F53E-4B9F-AABE-A1FFBFFC10C8Q45721626-9267BB32-E8E5-48AB-9D6F-95968ECF046DQ46664350-BECF4E9B-5B32-4CA8-96CD-382767D03453Q49478316-846159A0-79E9-4336-B8C9-7664846F2B2DQ53411662-A222FCF5-6E9D-4084-B2B5-EFF10EA2831FQ53765659-3F345C16-116B-47C0-BCA8-DA1B4273EF98Q58691692-3D0BB1F7-81C6-4588-A7CF-B30E45169BB1
P2860
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin.
@en
type
label
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin.
@en
prefLabel
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin.
@en
P2093
P50
P1476
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin.
@en
P2093
Elisa Stellin
Elisabetta Esposito
Enea Menegatti
Francesco Bonina
Lydia Paccamiccio
Markus Drechsler
P304
P356
10.1007/S11095-005-8176-X
P577
2005-12-01T00:00:00Z